Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-18T04:07:39.598Z Has data issue: false hasContentIssue false

Panic in Australia

Published online by Cambridge University Press:  16 April 2020

GD Burrows
Affiliation:
Department of Psychiatry, University of Melbourne, Austin and Repatriation Medical Centre, HeidelbergVictoria, 3084, Australia
TR Norman
Affiliation:
Department of Psychiatry, University of Melbourne, Austin and Repatriation Medical Centre, HeidelbergVictoria, 3084, Australia
SR Ellen
Affiliation:
Department of Psychiatry, University of Melbourne, Austin and Repatriation Medical Centre, HeidelbergVictoria, 3084, Australia
KP Maguire
Affiliation:
Department of Psychiatry, University of Melbourne, Austin and Repatriation Medical Centre, HeidelbergVictoria, 3084, Australia
FK Judd
Affiliation:
Department of Psychiatry, University of Melbourne, Austin and Repatriation Medical Centre, HeidelbergVictoria, 3084, Australia
Get access

Summary

Panic disorder is widespread in Australia, often in combination with other psychiatric conditions such as agoraphobia or major depression. Pharmacotherapy for panic disorder in Australia commenced with benzodiazepines, and later progressed to tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). More recently, treatment has moved towards use of the selective serotonin reuptake inhibitors (SSRIs), which are effective and better tolerated. Paroxetine is the first drug of this class to receive approval for treatment of panic disorder in Australia.

Information

Type
Research Article
Copyright
Copyright © Elsevier, Paris 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Submit a response

Comments

No Comments have been published for this article.